Anti quorum sensing and anti biofilm potential of anogeissus acuminata and mallotus roxburghianus muell. Against pseudomonas aeruginosa pao1

Sairengpuii Hnamte, Pattnaik Subhaswaraj, Sampath Kumar Ranganathan, Dinakara Rao Ampasala, Gangatharan Muralitharan, Busi Siddhardha

Anti quorum sensing and anti biofilm potential of anogeissus acuminata and mallotus roxburghianus muell. Against pseudomonas aeruginosa pao1

Číslo: 5/2018/2019
Periodikum: Journal of Microbiology, Biotechnology and Food Sciences
DOI: 10.15414/jmbfs.2019.8.5.1135-1140

Klíčová slova: Antibiotic resistance, Biofilm, Pseudomonas aeruginosa, Quorum sensing, Virulence factors

Pro získání musíte mít účet v Citace PRO.

Přečíst po přihlášení

Anotace: Pseudomonas aeruginosa causes severe persistent infections in immunocompromised patients by showing tolerance conventional antibiotic therapy by virtue of specialized hierarchy of quorum sensing (QS) network. The purpose of the study was to evaluate the efficacy of two Mizoram medicinal plants i.e., Anogeissus acuminata and Mallotus roxburghianus Muell. in attenuating QS regulated P. aeruginosa virulence. The crude leaf extracts were tested for their ability to combat QS associated virulence phenotypes such as pyocyanin production, LasB elastase and Staphylolytic activity and production of biofilm determinants such as alginate and exopolysaccharide in P. aeruginosa PAO1. The gas chromatography mass spectrometry (GC-MS) analysis revealed the presence of phytocompounds, the synergistic activity of which is responsible for the anti QS activity. The in silico studies provide the binding efficacy of obtained phytochemical with QS receptor protein, LasR. The in vitro studies followed by in silico analysis demonstrated the efficacy of phytochemical of A. acuminata and M. roxburghianus Muell. in competitively inhibiting the binding of natural ligand with LasR and thereby altering production of virulence phenotypes. The efficacy in down regulating bacterial virulence shown by A. acuminata and M. roxburghianus Muell. provides promising alternatives to develop next generation anti-pathogenic agents.